SHFM1 deficiency suppresses esophageal squamous cell carcinomas progression via modulating NF­&#954;B signaling and enhancing nature killer cell­mediated tumor surveillance.

Wu, Yijuan; Wang, Zhiyu; Li, Shengmian; Chen, Xianliang; Zhou, Shengyun

SHFM1 deficiency suppresses esophageal squamous cell carcinomas progression via modulating NFκB signaling and enhancing nature killer cellmediated tumor surveillance.

Wu, Yijuan; Wang, Zhiyu; Li, Shengmian; Chen, Xianliang; Zhou, Shengyun.

Afiliación

Wu Y; Department of Oncology and Immunology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050010, P.R. China.
Wang Z; Endoscopy Center, Xingtai People's Hospital, Xingtai, Hebei 054031, P.R. China.
Li S; Department of Oncology and Immunology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050010, P.R. China.
Chen X; Department of Gastroenterology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050010, P.R. China.
Zhou S; Department of Gastroenterology, Xingtai People's Hospital, Xingtai, Hebei 054031, P.R. China.

Exp Ther Med ; 25(5): 195, 2023 May.

Article en En | MEDLINE | ID: mdl-37090067

Palabras clave

NF-κB signaling pathway; esophageal squamous cell carcinomas; immune response; malignant behaviors; split hand and foot malformation 1

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Screening_studies Idioma: En Revista: Exp Ther Med Año: 2023 Tipo del documento: Article Pais de publicación: Grecia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google